Personal Care Products

Haoyue Care

Haoyue Care released FY2026 Q1 earnings on April 27 After-Market BJT: Actual Revenue CNY 974.68 M (Forecast CNY 4.325 B), Actual EPS CNY 0.39

Haoyue Care released FY2025 Q4 earnings on April 27 After-Market (BJT), actual revenue CNY 1.037 B, actual EPS CNY 0.1318

Haoyue Care released FY2025 Annual Earnings on April 27 After-Market (BJT), Actual Revenue CNY 3.756 B (Forecast CNY 3.889 B), Actual EPS CNY 1.08 (Forecast CNY 1.485)

Haoyue Care FY2026 Q1 Earnings Release on April 28 After-Market (BJT), Forecast Revenue CNY 4.325 B

Haoyue Care to release FY2025 earnings on April 28 After-Market (BJT), forecast revenue CNY 3.889 B, EPS CNY 1.485

Haoyue Care released FY2025 9 Months Earnings on October 27 Pre-Market (BJT), with actual revenue of CNY 2.718 B and EPS of CNY 0.9478

Haoyue Care released FY2025 Q3 earnings on October 27 Pre-Market (BJT), actual revenue CNY 958.49 M, actual EPS CNY 0.259

Haoyue Care FY2025 Q3 Earning Release on October 28, 2025 Pre-Market BJT

Haoyue Care released FY2025 Semi-Annual Earnings on August 29 After-Market (BJT), Actual Revenue: CNY 1.76 B, Actual EPS: CNY 0.69

Haoyue Care released FY2025 Q2 earnings on August 29 After-Market BJT, actual revenue CNY 848.89 M, actual EPS CNY 0.2687

Haoyue Care to Release FY2025 Semi-Annual Earnings on August 30, 2025 (BJT)

Huafu Securities Gives Huayue Nursing a Buy Rating

Edwin Sun from Tianfeng Securities Releases Research Report on Huoyu Nursing with Buy Recommendation

Huayue Nursing Care Obtains New Baby Pant-Type Diaper Design Patent

Southwest Securities Gives Huayue Nursing a Buy Rating

Hangzhou Hope Zouchuang Plans to Reduce Shares of Huayue Nursing Care

Huayue Nursing Care Stock Rises and Receives Buy Rating

Tianfeng Securities Analyst Sun Haiyang Gives Buy Rating to Haoyue Nursing Care

Hangzhou Haoyue Hygiene Products Co., Ltd Submits New Trademark Application

605009

According to the Zhitong Finance APP, Haoyue Care disclosed its third-quarter report for 2025. The company achieved revenue of 2.718 billion yuan in the first three quarters, a year-on-year increase of 33.18%; the net profit attributable to the parent company was 203 million yuan, a year-on-year decrease of 30.94%; the net profit excluding non-recurring gains and losses was 194 million yuan, a year-on-year decrease of 32.55%; and the basic earnings per share were 0.95 yuan

Zhitong

Haoyue Care released its performance for the first three quarters, with a net profit attributable to the parent company of 203 million yuan, a year-on-year decrease of 30.94%

According to the Zhitong Finance APP, Haoyue Care disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.76 billion yuan, a year-on-year increase of 34.03%; net profit attributable to the parent company was 148 million yuan, a year-on-year decrease of 23.47%; net profit excluding non-recurring gains and losses was 146 million yuan, a year-on-year decrease of 23.91%; basic earnings per share were 0.69 yuan

Haoyue Care released its semi-annual performance report, with a net profit attributable to the parent company of 148 million yuan, a year-on-year decrease of 23.47%

Haoyue Care announced plans to suspend investment in the Mexico production base project due to the impact of U.S. tariff measures on the local economy and the uncertainty in U.S.-Mexico relations, which has increased investment risks. The company will comply with relevant laws and regulations for information disclosure

Haoyue Care: Plans to suspend investment in the Mexico production base project

Haoyue Care continued to decline in the afternoon, with a drop of up to 3.43%, reporting at 40 yuan. Haoyue Care announced that from July 9, 2025, to July 28, 2025, Hope Innovation intends to reduce its holdings in the company by 1.07 million shares through centralized bidding, accounting for 0.5% of the company's total share capital. As of the date of this announcement, Hope Innovation holds 7,676,181 shares of the company, accounting for 3.57% of the company's total share capital. This reduction plan has been completed

Haoyue Care fell 3.43%, hoping to complete the reduction of 1.07 million shares of the company

Haoyue Care announced that its shareholder Hangzhou Xiwang Zhongchuang Industrial Investment Partnership will reduce its holdings of 1.07 million shares of the company through centralized bidding from July 9, 2025, to July 28, 2025, accounting for 0.50% of the company's total share capital. The reduction price range is between 39.56 and 41.76 yuan/share, with a total reduction amount of 42.9585 million yuan; after the reduction, it will hold 7.6762 million shares, accounting for 3.57%. This reduction plan has been completed

Haoyue Care: Hopes that Zhongchuang will reduce its holdings by 0.50%

According to the Zhitong Finance APP, Haoyue Care announced that Hangzhou Xiwang Zhongchuang Industrial Investment Partnership (Limited Partnership) plans to reduce its holdings by no more than 1.07 million shares, which is no more than 0.50% of the company's total share capital, due to its own funding needs. The reduction through centralized bidding will be conducted within three months after 15 trading days from the disclosure date of this reduction plan

Haoyue Care shareholders hope Zhongchuang plans to reduce holdings by no more than 1.07 million shares

300740

300888

301009

300886

301108

The beauty and personal care sector has shown strong fluctuations, with Hyea Aromas rising over 15%. JIEYA, SYG, Haoyue Care, Winner Medical, and Coco Healthcare have also seen significant gains

Winner Medical

Coco Healthcare

Hyea Aromas

JIEYA

Shenwan Hongyuan Research pointed out that Haoyue Care's revenue performance is good in the fourth quarter of 2024 and the first quarter of 2025, with a recovery in the growth of its main business of baby diapers, and the Jieting sanitary napkin brand is also gaining momentum. With the increase in the number of newborns, the demand in the domestic baby diaper industry is improving, and Haoyue continues to increase its market share. Based on these factors, the "Buy" rating for Haoyue Care is maintained

SWHY

Shenwan Hongyuan Research: Haoyue Care's main business recovery and brand efforts, maintaining a "Buy" rating

605179

002329

001206

603630

36Kr learned that, as of the time of publication, the consumer sector continues to be active, with beauty care and dairy industries leading the gains. Lafang has seen three limit-ups in four days, Beingmate has hit the daily limit, and companies such as Pinwo Foods, Knight Dairy, Panda Dairy, inm, Royal Group, Fulejia, YIYI, Nuobang, Qingsong, and Haoyue Care have also followed suit

36Kr

Royal Group

YIYI

Lafang

PANDAIRY

Green Pine

Fuerjia

Beingmate

PINLIVE

NBOND

The large consumer sector remains active, Lafang has 3 limit-ups in 4 days

603983

003006

600315

Marubi surged to the daily limit in the afternoon, Bawei shares rose over 10%, Runben shares, Wenkang Medical, and Shanghai Jahwa rose over 5%, while SYG, BAIYA CORPORATION, Haoyue Care, and JIEYA also followed suit. In terms of news, Zhao Chenxin, Deputy Director of the National Development and Reform Commission, stated at a press conference held by the State Council Information Office that China will introduce and implement several measures to stabilize employment and the economy, promoting high-quality development, and increase support for service consumption and the elderly care industry

Marubi

BAIYA CORPORATION

Shanghai Jahwa

养老产业

Runben Biotechnology

Beauty care concept stocks continue to rise, Marubi hits the daily limit in the afternoon

Haoyue Care(605009.SH)